1. 1) Han DH, Kwon OK, Byun BJ, et al.: A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976–1994). The Korean Society for Cerebrovascular Disease. Acta Neurochir (Wien) 142: 1263–1273; discussion 1273–1274, 2000
2. 2) Funaki T, Takahashi JC, Miyamoto S: Late cerebrovascular events and social outcome after adolescence: long-term outcome of pediatric moyamoya disease. Neurol Med Chir (Tokyo) 58: 240–246, 2018
3. 3) Jeon JP, Kim JE, Cho WS, Bang JS, Son YJ, Oh CW: Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults. J Neurosurg 128: 793–799, 2018
4. 4) Ding J, Zhou D, Paul Cosky EE, et al.: Hemorrhagic moyamoya disease treatment: a network meta-analysis. World Neurosurg 117: e557–e562, 2018
5. 5) Miyamoto S, Yoshimoto T, Hashimoto N, et al.: Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke 45: 1415–1421, 2014